The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation

被引:237
作者
Greggio, Elisa [1 ,2 ]
Zambrano, Ibardo [2 ]
Kaganovich, Alice [2 ]
Beilina, Alexandra [2 ]
Taymans, Jean-Marc
Daniels, Veronique [3 ]
Lewis, Patrick [2 ]
Jain, Shushant [2 ]
Ding, Jinhui [1 ]
Syed, Ali [2 ]
Thomas, Kelly J. [2 ]
Baekelandt, Veerle [3 ]
Cookson, Mark R. [2 ]
机构
[1] NIA, NIH, Neurogenet Lab, Bioinformat Facil, Bethesda, MD 20982 USA
[2] NIA, NIH, Cell Biol & Genen Express Unit, Bethesda, MD 20982 USA
[3] Katholieke Univ Leuven, Dept Mol & Cellular Med, Div Mol Med, Lab Neurobiol & Gene Therapy, B-3000 Louvain, Belgium
关键词
D O I
10.1074/jbc.M708718200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and apparently sporadic Parkinson disease. LRRK2 is a multidomain protein kinase with autophosphorylation activity. It has previously been shown that the kinase activity of LRRK2 is required for neuronal toxicity, suggesting that understanding the mechanism of kinase activation and regulation may be important for the development of specific kinase inhibitors for Parkinson disease treatment. Here, we show that LRRK2 predominantly exists as a dimer under native conditions, a state that appears to be stabilized by multiple domain-domain interactions. Furthermore, an intact C terminus, but not N terminus, is required for autophosphorylation activity. We identify two residues in the activation loop that contribute to the regulation of LRRK2 autophosphorylation. Finally, we demonstrate that LRRK2 undergoes intramolecular autophosphorylation. Together, these results provide insight into the mechanism and regulation of LRRK2 kinase activity.
引用
收藏
页码:16906 / 16914
页数:9
相关论文
共 34 条
[1]
LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-Linking familial and sporadic Parkinson's disease [J].
Bonifati, Vincenzo .
NEUROCHEMICAL RESEARCH, 2007, 32 (10) :1700-1708
[2]
G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort [J].
Bras, JM ;
Guerreiro, RJ ;
Ribeiro, MH ;
Januario, C ;
Morgadinho, A ;
Oliveira, CR ;
Cunha, L ;
Hardy, J ;
Singleton, A .
MOVEMENT DISORDERS, 2005, 20 (12) :1653-1655
[3]
Dimerization through the catalytic domain is essential for MEKK2 activation [J].
Cheng, JK ;
Yu, L ;
Zhang, DY ;
Huang, QJ ;
Spencer, D ;
Su, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (14) :13477-13482
[4]
Identification of potential protein interactors of Lrrk2 [J].
Daechsel, Justus C. ;
Taylor, Julie P. ;
Mok, Su San ;
Ross, Owen A. ;
Hinkle, Kelly M. ;
Bailey, Rachel M. ;
Hines, Jacob H. ;
Szutu, Jennifer ;
Madden, Benjamin ;
Petrucelli, Leonard ;
Farrer, Matthew J. .
PARKINSONISM & RELATED DISORDERS, 2007, 13 (07) :382-385
[5]
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase [J].
Deng, Junpeng ;
Lewis, Patrick A. ;
Greggio, Elisa ;
Sluch, Eli ;
Beilina, Alexandra ;
Cookson, Mark R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) :1499-1504
[6]
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family [J].
Funayama, M ;
Hasegawa, K ;
Ohta, E ;
Kawashima, N ;
Komiyama, M ;
Kowa, H ;
Tsuji, S ;
Obata, F .
ANNALS OF NEUROLOGY, 2005, 57 (06) :918-921
[7]
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1 [J].
Funayama, M ;
Hasegawa, K ;
Kowa, H ;
Saito, M ;
Tsuji, S ;
Obata, F .
ANNALS OF NEUROLOGY, 2002, 51 (03) :296-301
[8]
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity [J].
Gloeckner, CJ ;
Kinkl, N ;
Schumacher, A ;
Braun, RJ ;
O'Neill, E ;
Meitinger, T ;
Kolch, W ;
Prokisch, H ;
Ueffing, M .
HUMAN MOLECULAR GENETICS, 2006, 15 (02) :223-232
[9]
Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1 [J].
Greggio, Elisa ;
Lewis, Patrick A. ;
van der Brug, Marcel P. ;
Ahmad, Rili ;
Kaganovich, Alice ;
Ding, Jinhui ;
Beilina, Alexandra ;
Baker, Acacia K. ;
Cookson, Mark R. .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 (01) :93-102
[10]
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin [J].
Greggio, Elisa ;
Jain, Shushant ;
Kingsbury, Ann ;
Bandopadhyay, Rina ;
Lewis, Patrick ;
Kaganovich, Alice ;
van der Brug, Marcel P. ;
Beilina, Alexandra ;
Blackinton, Jeff ;
Thomas, Kelly Jean ;
Ahmad, Rill ;
Miller, David W. ;
Kesavapany, Sashi ;
Singleton, Andrew ;
Lees, Andrew ;
Harvey, Robert J. ;
Harvey, Kirsten ;
Cookson, Mark R. .
NEUROBIOLOGY OF DISEASE, 2006, 23 (02) :329-341